|
服务
产品  
|
Bradykinin (1-5)
| 名称
|
Bradykinin (1-5)
|
| 别名
|
|
| 序列（单字母缩写）
|
RPPGF
|
| 序列（三字母缩写）
|
{ARG}{PRO}{PRO}{GLY}{PHE}
|
| 基本描述
|
The bradykinin (BK) fragment (1-5) (RPPGF) is among the more stable of naturally occurring metabolites. Bradykinin (1-5) may be used as a marker for BK production in vivo. It is known that an intact Arg residue in the C-terminus is required for certain biological activities. BK 1-5 is the smallest peptide that can inhibit α-thrombin-induced platelet aggregation and secretion and calcium mobilization. Bradykinin (1-5) also prevents α-thrombin from cleaving the thrombin receptor peptide, NATLDPRSFLLR, between arginine and serine. Such antithrombin activities of BK 1-5 may contribute to the cardioprotective nature of kinins.
|
| 分子量
|
572.660
|
| 化学式
|
C27H40N8O6
|
| 纯度
|
> 95%
|
| 存储条件
|
Store the peptide at -20°C
|
| 注释
|
|
| Documents
|
|
| Figures
|
|
| Reference
|
Dielis AW, et al. The prothrombotic paradox of hypertension: role of the renin-angiotensin and kallikrein-kinin systems. Hypertension. Dec 2005; 46(6): 1236-1242.
Wu TJ, et al. Stimulation of luteinizing hormone-releasing hormone (LHRH) gene expression in GT1-7 cells by its metabolite, LHRH-(1-5). Endocrinology. Jan 2005; 146(1): 280-286.
Nieman MT, et al. Mapping the interaction of bradykinin 1-5 with the exodomain of human protease activated receptor 4. FEBS Lett. Jan 2005; 579(1): 25-29.
|
|
